Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells.
| Image |  |
|---|---|
| Description | scientific article published on August 2015 |
| Author/s |
author: Aaron Schimmer |
| Publication date | August 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |